Medical Advisory Board
Terence J. Colgan, MD
Mount Sinai Hospital
Toronto, Ontario, Canada
Dr. Colgan is an anatomical pathologist, and a practicing cyto- and surgical pathologist, with a particular interest in preventive oncology. Currently, he is Head of the Sections of Gynecological and Cytopathology at the Mount Sinai Hospital and a Professor in the Departments of Laboratory Medicine and Pathobiology and Obstetrics & Gynecology at the University of Toronto. He is actively involved in both teaching and research in pathology, and is a journal editor for Cancer (Cytopathology), Acta Cytologica, Archives of Pathology and Laboratory Medicine, International Journal of Gynecological Pathology, and Journal of Lower Genital Tract Disease. He is a past Chair of the Canadian Society of Cytology, the Society of Canadian Colposcopists, and the American Society of Cytopathology’s (ASC) Committee on Centers of Excellence. For a number of years he was a member of the College of American Pathologist’s Cytopathology Resource Committee. Currently, he is a member of council of the International Academy of Cytology, and Chair of the ASC Educational Development Committee. His primary research interests include the application of proteomics to the detection of endometrial disease, new technologies in cervical cancer screening, the screening and diagnosis of genital tract neoplasia, and hereditary cancer. Both the National Cancer Institute of Canada and Canadian Institutes of Health Research provide support for his research.
Robb W. Glenny, MD
University of Washington
Seattle, Washington
Dr. Glenny is the Division Head of Pulmonary and Critical Care Medicine and Professor of Medicine, Physiology and Biophysics at the University of Washington. Among his ongoing research interests are translational research in acute lung injury and 3D imaging and computer modeling of the respiratory tract. He has published extensively with over 120 papers in prestigious journals during the last 20 years. Dr. Glenny is active in professional society committee work for the American Thoracic Society, American Lung Association, American Heart Association and the American Physiologic Society. He is an associate editor for the Journal of Applied Physiology. He has received several awards for exemplary performance including: National Research Service Award, John Simon Guggenheim Memorial Foundation Award, Giles F. Filley Memorial Award in Respiratory Physiology and Medicine and the Fogarty Senior International Fellowship. He received his BS and MA degrees from Duke University in Biomedical Engineering and Computer Science, his medical doctorate from the University of Virginia, and subsequently specialized in pulmonary physiology. He was a visiting Professor at the Karolinska Institute in Stockholm, Sweden.
Edward P. Ingenito, MD, PhD
Havard Medical School
Boston, Massachusetts
Dr. Ingenito is an Assistant Professor of Medicine at the Harvard Medical School. He has specialized in critical care medicine and pulmonary medicine at the Brigham and Women’s Hospital in Boston where he also served as Director of the Medical Intensive Care Unit and the Pulmonary Function Lab. Dr. Ingenito has received several awards for outstanding teaching and scholarly work. He has published widely on the subjects of pulmonary function and chronic obstructive pulmonary disease (COPD), and is regarded as a leader in the field. Dr. Ingenito has several patents pending in the area of lung volume reduction therapy for patients who suffer from emphysema. Dr. Ingenito received his BS degree in biology, his MS in Mechanical Engineering and his PhD in Biomedical Engineering from MIT and his Medical Doctorate from the Harvard Medical School.
Gene F. Pawlick, MD
Retired, Kaiser Permanente Medical Group
San Mateo, California
Dr. Pawlick recently retired as the Medical Director of the Kaiser Permanente Medical Group, Regional Reference Laboratories in Berkeley and Richmond, California, where he directed clinical laboratory services from 1993 to 2007. These laboratories comprise the largest reference clinical laboratory organization in the Kaiser Permanente system, performing over 70% of all laboratory testing originating in the Northern California region of 3.3 million health plan members. Dr. Pawlick has been a featured speaker at the American Association of Clinical Chemistry programs and the War College. At Kaiser Permanente, Dr. Pawlick pioneered clinical studies in the area of cancer screening and diagnosis and has participated in related hearings at the FDA as a field expert. He received his BS from the University of San Francisco, his MD from Saint Louis University, and took his residency at Kaiser Hospital in San Francisco. He is a graduate of the Advanced Leadership Program at the Keenan-Flagler School of Business at the University of North Carolina. He is Board Certified in Anatomic and Clinical Pathology. He is also an avid fly fisherman.
James P. Smith, MD
Weill Medical College of Cornell University
Englewood, New Jersey
Dr. Smith is a Professor of Medicine at Weill Medical College of Cornell University where he founded the Respiratory Intensive Care Unit at The New York Hospital. This Unit, one of the first in the United States, provided the platform for his early clinical research in COPD and acute respiratory failure. The focus of his interest for the past fifteen years has been in the area of the early detection, diagnosis and treatment of lung cancer. Dr. Smith is a Fellow of the American College of Physicians and the American College of Chest Physicians. He has served on numerous professional society boards, including as President of the NY Trudeau Society and the NY Lung Association, and as Chairman of the Medical Advisory Board of the Cystic Fibrosis Association. He is a founding member of the Early Lung Cancer Action Project. He is the recipient of the National Leadership Award and the Life and Breath Award of the American Lung Association. He is the author of over fifty peer review articles and more than twenty books/chapters in the field of pulmonary and critical care medicine. Dr. Smith received his BS degree from Georgetown University and his MD from Georgetown School of Medicine.
Javier J. Zulueta, MD, FCCP
University of Navarra School of Medicine
Pamplona, Spain
Dr. Zulueta is an Associate Professor in the Department of Medicine at the University of Navarra School of Medicine in Pamplona, Spain, where he is Director of the Pulmonary Service. His research interests include lung cancer screening and the use of molecular biomarkers in early lung cancer detection, acute lung injury and cardio-pulmonary exercise physiology, and he has published over 40 research articles and book chapters. He is a Fellow of the American College of Chest Physicians, Member of the American Thoracic Society and Member of the European Respiratory Society. Dr. Zulueta received his Medical Doctorate from the Universidad Complutense in Madrid, Spain. His specialization in Pulmonary and Critical Care Medicine was at New England Medical Center, Tufts University School of Medicine, Boston, MA.
David C. Wilbur, MD, FACP
Massachusetts General Hospital & Harvard Medical School
Boston, Massachusetts
Dr. Wilbur is an anatomic pathologist practicing at Massachusetts General Hospital in Boston, Massachusetts, and is Professor of Pathology at Harvard Medical School. He is currently the Director of Clinical Imaging, and was previously the Director of the Cytopathology Unit. He has an active practice in the areas of cytopathology, and gynecologic and breast surgical pathology. He is the co-editor of the 3rd edition of the texbook Comprehensive Cytopathology and his relevant research interests include computerization in pathology, most notably automated screening instrumentation and digital telepathology.
